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Loss of function of the peritoneal membrane is associated
with peritonitis. Adenosine levels in sites of inflammation
were shown to increase and exhibit immunoregulatory
effects. Our aim was to elucidate the regulatory role of
adenosine during peritonitis and to test the involvement of
peritoneal mesothelial cells (PMC) in adenosine regulation. In
a mice model of Escherichia coli peritonitis, the adenosine A2A
receptor (A2AR) agonist (CGS21680) prevented leukocyte
recruitment and reduced tumor necrosis factor alpha (TNF-a)
and interleukin-6 (IL-6) levels. Peritonitis induced the
elevation of adenosine with a peak at 24 h. Analysis of
adenosine receptor levels on peritoneum showed that A1
receptor (A1R) protein levels peak at 12 h after inoculation
and then return to baseline at 24 h, whereas high affinity
A2AR protein levels peak at 24 h concomitantly with the peak
of adenosine concentration. Low affinity A2B receptor (A2BR)
levels elevated slowly, remaining elevated up to 48 h. In
human PMC (HPMC), the early cytokines, IL-1-a, and TNF-a
upregulated the A2B and A2A receptors. However, interferon-c
(IFN-c) upregulated the A2BR and decreased A2AR levels.
Treatment with the A2AR agonist reduced IL-1-dependent IL-6
secretion from HPMC. In conclusion, the kinetics of adenosine
receptors suggest that at early stage of peritonitis, the A1R
dominates, and later its dominance is replaced by the G
stimulatory (Gs) protein-coupled A2AR that suppresses
inflammation. Early proinflammatory cytokines are an
inducer of the A2AR and this receptor reduces their
production and leukocyte recruitment. Future treatment with
adenosine agonists should be considered for attenuating the
damage to mesothelium during the course of acute
peritonitis.
Kidney International (2006) 70, 675–681. doi:10.1038/sj.ki.5001609;
published online 21 June 2006
KEYWORDS: adenosine; peritonitis; peritoneal membrane; inflammation
The long-term success of peritoneal dialysis is often
endangered by structural injury to the peritoneal membrane.
This injury is characterized by replacement of the normal
peritoneal structure with fibrotic tissue, profusion of
capillary vessels, and loss of the mesothelial layer. These
morphological alterations are sometimes associated with loss
of peritoneal membrane function, leading to the necessity for
discontinuation of peritoneal dialysis.1,2 Apparently, the
inflammatory process (which accompanies bacterial peri-
tonitis) is one of the factors which damage the peritoneal
membrane. During peritonitis, leukocytes that are shifted
into the peritoneal cavity release toxic molecules in order to
combat the bacterial invasion. However, these molecules may
also be harmful to the peritoneal structure. Moreover,
polymorphonuclear neutrophils are recruited into the
peritoneal cavity via diapedesis. During this process, these
cells strongly adhere to the mesothelium and release
proinflammatory compounds such as proteolytic enzymes
and reactive oxygen species which possibly injure the
peritoneal membrane.3 Consequently, neutrophil accumula-
tion and their cytotoxic function in the peritoneal exudates
must be strictly regulated in order to allow the killing of
invading pathogens with minimal damage to the peritoneal
tissue.
Peritoneal mesothelial cells (PMC) are not merely
bystanders in inflammatory processes, but rather play a
central role during inflammation process, within peritoneal
cavity.4 First, as we and others have shown, PMC are a potent
source for various proinflammatory mediators, including
interleukin (IL)-1a and IL-1b, IL-15, IL-8, monocyte
chemotactic protein (MCP)-1, RANTES, IL-6, and growth
factors such as transforming growth factor (TGF)-b.5–9 In
addition, PMC constitutively express intracellular adhesion
molecule-1,6 vascular cell adhesion molecule-1, and platelet
endothelial cell adhesion molecule-1.10 PMC are also capable
of antigen presentation to lymphocytes and interacting with
them.6 These data underline the role of the mesothelial layer
as an important immunomodulator during inflammatory
process taking place in the peritoneal cavity.
Over the past few years, a vast number of investigations
have reported an involvement of adenosine as an anti-
inflammatory mediator.11,12 Adenosine is an endogenous
purine nucleoside that following its release from cells or after
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being formed extracellularly diffuses into the cell membrane
of surrounding cells where it binds specifically to four known
subtypes of adenosine receptors, referred to as A1R, A2AR,
A2BR, and A3R.
13–15 All are members of the superfamily of G
protein-coupled receptors. The A2AR interacts with the G
protein Gs and the (A2BR) interacts with the G proteins Gs
and Gq (Gq is Ga subunit which stimulates phospholipase C)
to stimulate adenylyl cyclase activity thereby causing
accumulation of intracellular cAMP levels,11,16 which have
potent immunosuppressive effects.17 In contrast, the A1R and
A3R, through interaction with members of the Gi/Go family,
inhibit adenylyl cyclase and decrease levels of cAMP.14
Adenosine has a direct effect on immune cells and
contributes to the resolution of inflammation mainly
through the A2AR.
18–21 By downregulating neutrophil activity
and macrophage activation, adenosine inhibits generation of
reactive oxygen species and proinflammatory cytokines such
as tumor necrosis factor alpha (TNF-a), IL-1, IL-6, etc.12,21–23
Based on these findings, we hypothesized that adenosine
may play an important role in regulating the anti-
inflammatory response during acute peritonitis and thus,
minimize the peritoneal membrane damage. In order to
confirm this hypothesis, we tested the effect of the A2AR
agonist on the intraperitoneal influx of leukocytes as well as
the proinflammatory cytokine production during peritonitis.
We also examined adenosine levels in the peritoneal cavity
and the levels and regulation of adenosine receptors on PMC.
RESULTS
A2AR agonist blocks intraperitoneal influx of leukocytes and
reduces TNF-a and IL-6 levels
As it has been reported that the A2AR is involved in the anti-
inflammatory response,18–20 we first tested the effect of its
specific agonist, CGS-21680 on the intraperitoneal influx of
leukocytes during acute peritonitis. As shown in Figure 1,
treatment of Escherichia coli-inoculated mice with CGS-
21680 significantly inhibited the influx of leukocytes into the
peritoneal cavity (3.2 106 vs 13.2 106 cells in control
group, Po0.01). Similar to this effect, the A2AR agonist
strongly reduced TNF-a and IL-6 levels locally and
systemically in the infected mice. Levels in the peritoneal
fluid (from 48.9 to 22.5 pg/ml, P40.05 and from 101.8 to
20.3, Po0.05, respectively) and in the serum (from 471.5 to
182.6 pg/ml, Po0.001 and from 150 to 25 pg/ml, Po0.01,
respectively), as shown in Figure 2.
Adenosine levels during peritonitis
The next stage was to examine adenosine kinetics during
peritonitis in relation to the inflammatory process evolution.
At different time points, after intraperitoneal E. coli
inoculation, peritoneal lavage was performed and serum
samples were taken for adenosine determination. No
significant changes of adenosine levels were observed in
blood following inoculation. Peritoneal leukocytes were
counted, and adenosine levels in supernatants were examined
concomitantly. As shown in Figure 3a, there is a rapid influx
of leukocytes into the peritoneal cavity that reached peak at
12 h, which subsequently recedes slowly over the next 60 h.
Adenosine levels rose gradually and reached a maximal level
of 2.270.2 mM (vs 0.370.1) at 24 h and afterwards decreased
back to basal levels (Figure 3b). The fact that adenosine levels
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Figure 1 | Effect of adenosine A2AR agonist on leukocyte
recruitment in the course of acute peritonitis in mice. CD1 mice
were injected with saline or inoculated with a sublethal dose of
E. coli. At 1 h before inoculation, mice were pretreated with saline or
with the A2AR agonist, CGS-21680 (2 mg/kg). Cell exudates were
collected at 24 h by peritoneal lavage and counted. The figure is a
representative of three similar experiments. Results are presented as
mean7s.e. N¼ 5 for each group, **Po0.01.
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Figure 2 | Effect of A2AR agonist, CGS-21680 on TNF-a and IL-6
levels in the course of E. coli-induced peritonitis. CD1 mice were
injected with saline or inoculated with a sublethal dose of E. coli, and
also injected with saline or the A2AR agonist CGS-21680. At 24 h after
inoculation, peritoneal lavage was performed, and cell-free
supernatants were collected and assayed for (a) IL-6, (b) TNF-a by
enzyme-linked immunosorbent assay kits (R&D Systems). (c, d)
At 6 or 3 h after inoculation respectively, blood samples from the
heart were collected and analyzed for IL-6 and TNF-a, respectively.
The figure is a representative of three similar experiments. Results are
presented as mean7s.e. N¼ 5 for each group, *Po0.05.
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peaked at 24 h after inoculation simultaneously to when
leukocyte infiltration began to diminish suggests that there is
causative linkage between these two events.
Adenosine receptors levels in mesothelial cells and
leukocytes
As there is no information reported to date, as whether
adenosine receptors exist on peritoneal mesothelial cells, it
was required to examine it for a complete picture of our
model. As shown in Figure 4, mRNA and protein levels of
A1R, A2AR, and A2BR receptors subtypes were upregulated
shortly after E. coli inoculation. A1R mRNA levels peaked 6 h
after inoculation followed by an increase in protein levels that
peaked at 12 h and returned to basal levels at 24 h. Similarly,
A2AR mRNA levels peaked at 6 h but remained elevated as
long as 24 h and then diminished to levels lower than basal.
There was also an increase in A2AR protein levels that peaked
at 24 h twofold higher than basal levels and then decreased.
The basal mRNA and protein levels of the A2BR were very low
and slowly increased during the course of peritonitis up to
48 h. However, A3R mRNA levels decreased threefold lower
than basal shortly after inoculation and remained at the same
level up to 48 h.
Correspondingly, in peritoneal leukocytes, A2AR, A2BR
receptor mRNA levels were upregulated after E. coli
inoculation, A2AR mRNA levels peaked at 24 h and decreased
to levels lower than basal, whereas A2BR level slowly increased
up to 72 h after inoculation (Figure 5b).
The effect of inflammatory cytokines on adenosine receptors
To elucidate which mechanism regulates the levels of
adenosine receptors during peritonitis, primary culture of
human PMC (HPMC) were exposed to various proinflamma-
tory cytokines. Different levels of the A2A and A2B receptors on
HPMC were demonstrated. In the presence of IL-1, TNF-a,
and IFN-g individually or in combination, there was
upregulation in mRNA and protein levels of the A2BR
(Figure 6). In a similar manner, mRNA and protein levels of
A2AR in the presence of IL-1 and TNF-a were also upregulated.
In contrast, IFNg strongly decreased A2AR mRNA and protein
levels both alone and in combination with IL-1 and TNF-a
(8.770.7 vs 0.770.1, Po0.01 for mRNA and 9233.07200.1
vs 3116.27514.4, Po0.05 for protein levels).
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Figure 3 | Kinetics of adenosine generation in course of
E. coli-induced peritonitis. CD1 mice were inoculated with a
sublethal dose of E. coli. At the indicated time points after
inoculation, peritoneal lavage was performed and (a) total leukocyte
counts were determined. (b) Adenosine levels from peritoneal lavage
were determined by HPLC. The figure is a representative of two
similar experiments. Results are presented as mean7s.e. N¼ 4 for
each group.
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Figure 4 | Adenosine receptors levels in peritoneal mesothelial cells during peritonitis. CD1 mice were inoculated with a sublethal dose of
E. coli. At the indicated time points after inoculation, mesothelial monolayers covering the liver were analyzed for (a) RNA levels of A2AR, A2BR,
A1R, and A3R by real-time PCR and (b, c) for protein levels by Western blot analysis of A2AR, A2BR, and A1R, using specific antibodies.
(b) Represent the densitometry (mean7s.e.) of the protein blot depicted in (c). The figure is a representative of three similar experiments.
Results are presented as mean7s.e. N¼ 4 for each group.
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The effect of adenosine, and adenosine receptor agonists
and antagonists on cytokine secretion from HPMC
To better understand the regulatory role of adenosine during
peritonitis, one must take into consideration the complexity
of receptor interactions. We used specific adenosine receptor
agonists and antagonists in order to distinguish the
expression of each receptor, on IL-1-dependent IL-6 secretion
from HPMC. As shown in Figure 7, adenosine alone
(0.1–10 mM) had no significant effect on IL-6 secretion.
However, when adenosine was combined with the A1R
antagonist DPCPX (8-cyclopentyl-1, 3-dipropylxanthine), it
significantly reduced IL-6 levels in a dose-dependent manner
(57% inhibition at 10 mM of adenosine, Po0.01). In the
presence of the A2 receptor antagonist, DMPX (1,3-dimethyl-
7-propargylxanthine), adenosine significantly increased IL-6
production at 10 mM (722772 vs 1033759). Conversely,
adenosine had no significant effect on IL-6 secretion in the
presence of the A3 receptor antagonist 9-chloro-2-(2-
furanyl)-5-((phenylacetyl)amino)-[1,2,4]triazolo[1,5-c]quina-
zoline (MRS). To further test the involvement of the A2AR in
the inhibition of IL-6, we tested the effect of the A2R agonist
CGS21860 on IL-6 secretion. As shown in Figure 6d, CGS-
21860 at doses of 1–10 mM significantly reduced IL-6 secretion
in a dose-dependent manner (21% inhibition at 10 mM,
Po0.01).
DISCUSSION
The results of the present study show that administration of
the A2AR agonist, CGS-21680, causes a significant decline in
leukocyte count in peritoneal exudates. Similarly, Zhang et al.
showed that propentofylline, an atypical xanthine derivative
that increases adenosine levels by blocking adenosine uptake,
reduced polymorphonuclear leukocyte recruitment during
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Figure 5 | Expression of adenosine receptors on peritoneal
leukocytes during peritonitis. CD1 mice were injected with saline or
inoculated with a sublethal dose of E. coli. At the indicated time
points after inoculation, peritoneal lavage was performed, peritoneal
leukocytes were harvested for RNA extraction and (a) A2AR mRNA
levels, (b) A2BR mRNA levels were determined by real-time
polymerase chain reaction. The figure is a representative of two
similar experiments. Results are presented as mean7s.e. N¼ 3 for
each group.
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Figure 6 | The effect of pro-inflammatory cytokines on A2A and A2B receptor levels in HPMC. HPMC were stimulated with IL-1 (100 U/ml),
TNF-a (10ng/ml), IFN-g (100 U/ml) alone or in combination. (a, b) After 3 h of stimulation, total RNA was extracted from cells and real-time PCR
was performed for (a) A2AR, (b) A2BR. (c, d) After 8 h of stimulation, total protein was extracted from cells and analyzed by Western blot for
(c) A2AR, (d) A2BR. The figure is a representative of three similar experiments. Results are presented as mean7s.e. N¼ 3 for each group,
*Po0.05, **Po0.01.
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acute peritonitis, an effect that was counteracted by selective
adenosine A2AR antagonists.
24 Moreover, administration of
A2AR agonist reduced TNF-a and IL-6 levels in the serum and
peritoneal fluid of infected mice. This effect of reducing
TNF-a was shown also in in vitro studies on lipopolysaccha-
ride-induced RAW 264.7 macrophages and U937 cells and in
vivo, in plasma of LPS-induced mice treated with the A2AR
agonist.18,25 These results support the notion that adenosine
moderates the intensity of the inflammatory response to
bacterial invasion of the peritoneum, as the anti-infla-
mmatory effect of adenosine is mediated mainly through
the A2AR.
18–20
A steep rise in leukocyte count was observed soon after
E. coli inoculation peaking at 12 h, gradually declining in the
succeeding hours. Noteworthy is the rise of adenosine levels
in the peritoneal exudate that peaked at 24 h to a level
approximately 400% higher than the level before inoculation
with bacteria, whereas a sharp drop in leukocyte count
occurred suggesting that these two events are cause related.
The next stage was to investigate the expression and
kinetics of the four subtypes of adenosine receptors in
peritoneal mesothelial cells and leukocytes during bacterial
peritonitis. Expression of A1R, A2AR, A2BR, and A3R was
found both in mRNA and protein levels on the peritoneal
mesothelial cells (see Figure 4). A1 receptor protein levels
peaked at 12 h and then returned to baseline at 24 h, whereas
high-affinity A2AR protein levels remained at their summit
up to 24 h at which point adenosine concentration achieved
its highest level in the peritoneal fluid. In contrast low-
affinity A2BR protein and mRNA levels showed a different
pattern: a slow and sustained elevation up to 48 h. According
to Olah and Stiles,16 A2AR interaction with Gs and A2BR
interaction with Gs and Gq stimulate cAMP production
which is endowed with strong immunosuppressive proper-
ties. Therefore, high expression of A1R immediately after
inoculation causes a decrease in cAMP levels, which give a
rise for local proinflammatory cytokines and leukocyte
migration, hence allowed an adequate and effective immune
response to the invading microorganisms. In contrast, the
increase in A2AR and A2BR at late phases of peritonitis is
probably associated with increased cAMP levels, which
markedly decreases local proinflammatory cytokines levels
and leukocyte recruitment, hence restraining inflammatory
flames. Therefore, the sequential increase of A1R, A2AR, and
A2BR observed in our study suggests that they are finely
regulated to allow an adequate signal from adenosine during
the different phases of peritonitis. The early increase of the
A1R that peaks at 12 h allows leukocyte influx into the
inflamed area thus enabling an effective attack of the bacteria.
The upregulation of the A2A and A2B receptors that appear at
a later stage moderates the number of leukocytes in the
exudates, thereby reducing the potential damage to normal
peritoneal tissue caused by cytotoxic and destructive
molecules released by leukocytes. Furthermore, the dominant
A2AR in PMC and leukocytes is replaced by the dominance of
A2BR at 48 h. This switch between the high-affinity A2AR and
the low-affinity A2BR suggests that the anti-inflammatory
pathway of adenosine is desensitized at this stage.
The aim in our experiments was to explore the regulatory
effect of the early pro-inflammatory cytokines, TNF-a, and
IL-1, on the expression of these two A2R. We found that
TNF-a and IL-1 stimulated the expression of the A2A and A2B
receptors. This phenomenon might explain the increase of
these receptors at the early phase of peritonitis. In contrast,
IFN-g significantly reduced the levels of the A2AR but
increased the A2BR. These data suggest that IFN-g, which is
secreted at the late phase of peritonitis from T cells and
natural killer (NK) cells, is responsible for the in vivo late
desensitization of the A2 system by converting the dominance
to the low-affinity A2BR (Figure 6). These data are consistent
with other studies which have shown that proinflammatory
cytokines modulate A2AR and A2BR expression and function
on human dermal microvascular endothelial cells and in
human monocytic THP-1 cells.26,27
The complex relationship between the different adenosine
receptors can be demonstrated by their mutual effect on IL-6
modulation. Only unopposed stimulation of A2AR by its
specific agonist CGS-21680 or by adenosine itself but in the
presence of concomitant blockade of A1R (DPCPX (8-
cyclopentyl-1, 3-dipropylxanthine)) inhibited IL-1-induced
IL-6 production by HPMC. The simultaneous stimulation of
all receptor types by adenosine had no effect on IL-6
production, which demonstrates the balance of opposite
stimuli. The combination of four types of receptor with their
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Figure 7 | Production of IL-6 by HPMC after stimulation of IL-1 in
the presence of adenosine and adenosine receptor agonists and
antagonists. HPMC were stimulated with IL-1 (100 U/ml) and
treated with different concentrations of adenosine and with
(a) A1R antagonist DCPCX (10 nM), (b) A2R antagonist
DMPX (1,3-dimethyl-7-propargylxanthine) (10 mM), (c) A3R antagonist
MRS (10 mM), and (d) A2AR agonist CGS-21860 (1–10 mM). At 24 h
after incubation, the medium was collected and analyzed for IL-6
levels by enzyme-linked immunosorbent assay. The figure is a
representative of four similar experiments. Results are presented as
mean7s.e. N¼ 3 for each group, *Po 0.05, **Po 0.01.
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diverse expression, affinity, and link to G-protein different
subunits is an essential condition for the realization of precise
and variable regulatory functions by a single molecule.
In conclusion, we have shown that the A2AR agonist
reduces cytokine production and leukocyte recruitment in
infected animals. Furthermore, we provided evidence that
adenosine is upregulated at the initial phase of peritonitis and
have traced the expression and regulation of its receptors by
various cytokines during this process. These results
are consistent with our hypothesis that adenosine when
released during a bacterial attack of the peritoneum plays
an important regulatory role in the intensity of the
inflammatory response. This findings may have important
implications for patients who forced to discontinue perito-
neal dialysis treatment as a result of bacterial peritonitis.1,2
MATERIALS AND METHODS
Mice, bacterial strains, and drugs
CD1 female mice aged 10–12 weeks (Harlan, Jerusalem, Israel) were
maintained in the animal laboratory of the Soroka Medical Center.
Experiments were conducted with the permission of the Israel
Committee for Animal Experiments.
E. coli were grown in Luria–Bertani broth (Conda Laboratories,
Madrid, Spain) and harvested during the log phase. Bacteria aliquots
in Luria–Bertani broth containing 30% glycerol were stored frozen at
701C.
Adenosine (Adenocor) was purchased from Sanofi Winthrop
(Auckland, NZ). Adenosine receptor agonists and antagonists were
purchased from Sigma (Rehovot, Israel). These included CGS-21680
which is an agonist of A2A receptor; A2 receptor antagonist DMPX
(1,3-dimethyl-7-propargylxanthine); A1 receptor antagonist DPCPX
(8-cyclopentyl-1, 3-dipropylxanthine); and A3 receptor antagonist
MRS-1220.
Induction of peritonitis and drug injection
Peritonitis was induced in CD1 mice by intraperitoneal (i.p.)
inoculation of the sublethal dose of E. coli (1.5 107 colony-forming
unit). Adenosine agonists and antagonists were injected i.p. before
E. coli inoculation.
Lavage, leukocyte counting, and cytokine detection
At different time points after E. coli inoculation, animals were killed
and peritoneal lavage was performed with phosphate-buffered saline
containing 2% bovine serum albumin and 5 mM ethylenediamine-
tetraacetic acid. After centrifugation at 400 g for 10 min, the cell-free
supernatants were removed and kept frozen at 201C until analysis.
TNF-a and IL-6 concentrations were measured by duoset enzyme-
linked immunosorbent assay kits (R&D Systems, Minneapolis, MN,
USA). Leukocytes from lavage after trypan blue staining were
counted using an improved Neubaur hemocytometer. Cell count
was carried out blindly on coded tubes by the same person for all the
experiments.
Serum cytokine detection
Peritonitis was induced by inoculation of E. coli. At different time
points, animals were killed, and a 1 ml syringe flushed with heparin
was used to draw a blood sample from their hearts. In preliminary
experiments, we found that following bacterial inoculation, serum
TNF-a levels peak at 1.5–3 h and IL-6 levels peak at 6–10 h.
Therefore, animals were bled at 3 h for TNF-a determination and
6 h for IL-6 determination. The samples were stored on ice
before centrifugation at 1000 g and 41C for 10 min. The cell-free
supernatants were collected and frozen at 201C for future analysis.
TNF-a and IL-6 serum concentrations were quantified by duoset
enzyme-linked immunosorbent assay kits (R&D Systems, Minnea-
polis, MN, USA).
Imprints of mice PMC and adenosine receptor determination
Peritonitis was induced by inoculation of E. coli as described above.
At the indicated time points, microscope slides (Superfrost plus,
Menzel-Glaser, Germany) were applied to the anterior liver surface
for 15–20 s by peeling off the mesothelial monolayer. The slides were
washed with phosphate-buffered saline to remove blood and
non-adherent cells. Two imprints were taken from each animal.
mRNA analysis
Total RNA was extracted from mesothelial monolayers imprinted on
the microscopic slide, from HPMC, or peritoneal leukocyte using
RNAeasy Mini Kit (Qiagen, Hilden, Germany). cDNA was prepared
as previously described.8 Quantitative real-time polymerasr chain
reaction (QPCR) assays were carried out for b-actin, glyceraldehyde
3-phosphate dehydrogenase, A1, A2A, A2B, and A3 receptors with the
following primers: b-actin sense, GGG TCA GGA GGA TTC CTA
TG, b-actin antisense, GGT CTC AAA CAT GAT CTG GG;
glyceraldehyde 3-phosphate dehydrogenase sense, CAA TGC ATC
CTG CAC CAC CAA, glyceraldehyde 3-phosphate dehydrogenase
antisense, GTC ATT GAG AGC AAT GCC AGC; A1 sense, TAC ATC
TCG GCC TTC CAG GTC G, A1, anti-sense, AAG GAT GGC CAG
TGG GAT GAC CAG; A2AR sense, ATT TGT GCC AGC CAG GAA
GCC, A2AR antisense, GCA TCC GGG ACT TTA AAC CAC AGA;
A2BR sense, ATT TGT GCC AGC CAG GAA GCC, A2BR antisense,
GCA TCC GGG ACT TTA AAC CAC AGA; A3R sense, ACC ACT
CAA AGA AGA ATA TG, A3R anti-sense, ACT TAG CTG TCT TGA
ACT CC. cDNAs were diluted ninefold, mixed with primers
(0.2 mM) and Thermo start master mix (ABgene, Surrey, UK).
Reaction was carried out in Rotor-Gene real-time PCR machine
(Corbett-Research, Northlake, Australia).
Western blot analysis
For determination of protein levels, mesothelial cells were harvested
with RadioImmunoProtection Assay (RIPA) (150 mM NaCl, 50 mM
Tris HCl pH-7.4, 1% NP-40, 0.25% Na deoxycholate, 1 mM ethylene
glycol tetra acetate) after which protease inhibitor cocktail (Sigma,
Rehovot, Israel) was added. After centrifugation at 13000 g for
30 min, the supernatants were taken for total protein determination
by the bicinchoninic acid (BCA) protein assay kit (Pierce, Rockford,
IL, USA). In total, 20 mg of total protein from each sample was
subjected to 12% sodium dodecyl sulfate–polyacrylamide gel
electrophoresis under reducing conditions and after heating. The
gels were blotted onto polyvinylidine difluoride membrane (Bio-
Rad, Hercules, CA, USA) and probed with specific antibodies: rabbit
anti-adenosine A2AR or A2BR affinity-purified polyclonal antibody
(Chemicon, Temecula, CA, USA), rabbit anti-rat A1R (Alpha
Diagnostic International, San Antonio, TX, USA), and Actin Ab-1
monocloonal antibody (Oncogene, San Diego, CA, USA). The
membrane was then probed with goat anti-rabbit immunoglobulins
conjugated to peroxidase agent (Dako, Copenhagen, Denamark).
Antigen–antibody complexes were subsequently visualized by
Western LightningTM Chemiluminescence Reagent Plus (PerkinEl-
mer, Boston, MA, USA).
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Preparation of HPMC
HPMC were isolated from pieces of omentum of approximately
6 cm2 obtained during elective abdominal surgery (with informed
consent of the patients) and were isolated, as previously described.28
As the harvested cells had to be identified as mesothelial cells,
samples of each HPMC preparation were morphologically inspected
as previously described.29 Cells were grown and experiments were
carried out in M199 medium containing 10% heat-inactivated fetal
calf serum, 2 mM L-glutamine, 100 U/ml penicillin, 100mg/ml
streptomycin, and Biogro 2TM (2%, Biological Industries, Beit
Haemek, Israel). Experiments were performed on cells from the
second to fourth passages in 12-well plates after cells reached
confluence.
Adenosine determination and HPLC analysis
For adenosine determination in mice peritoneal lavage, 900 ml lavage
fluid was placed in a polystyrene tube containing 100 ml stop
solution (2.3 mM erytro-9(2-hydroxynon-3-yl)-adenine and 20 mM
dipyridamole) designed to inhibit the metabolism and cellular
uptake of adenosine.
Adenosine levels were measured in deproteinated fluid by HPLC
as previously described.30,31
Statistical analysis
Data are presented as mean7s.e. Statistical analysis was performed
by analysis of variance. P-values below 0.05 were considered
significant.
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